血清孕酮、β-hCG、E2联合检测用于预测早期先兆流产结局的价值研究

摘要

目的：探讨血清孕酮、β-hCG、E2联合检测用于预测早期先兆流产结局的价值。方法：选择本院门诊及住院收治确诊的早期先兆流产患者52例作为研究对象，根据妊娠结局，分为安胎成功组42例，安胎失败组10例。比较两组血清孕酮、β-hCG、E2水平的差异。结果：安胎成功组的各孕周血清孕酮水平均高于安胎失败组，在6、9孕周时差异具有统计学意义（P<0.05）；安胎成功组在6、9孕周的β-hCG、E2水平均明显高于安胎失败组（P<0.05）。结论：血清孕酮、β-hCG、E2联合检测能够可靠、真实反映孕妇体内激素实际增长情况，有助于预测早期先兆流产结局。%Objective:To investigate value of combining detection of serum progesterone,β-hCG,E2 in predicting early threatened abortion outcomes. Method:52 patients with early threatened abortion in our hospital were selected. According to the pregnancy outcome,successful tocolysis group of 42 cases,failure tocolysis group of 10 cases. Serum progesterone,β-hCG,E2 in two groups were compared. Result:Serum progesterone in successful tocolysis group was higher than failure tocolysis group in different gestational weeks,and had significant difference in 6,9 gestational weeks (P<0.05);β-hCG and E2 in successful tocolysis group was significantly higher than failure tocolysis group in 6,9 gestational weeks(P<0.05). Conclusion:Combining detection of serum progesterone,β-hCG,E2 can truely reflect the maternal hormone actual growth. It is helpful to predicte early threatened abortion outcomes.